Immun’Âge® Granted Japanese Patent Recognizing Activation of Nrf2, the Body’s Master Cellular Defense Pathway

Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...
Targeted Oncology

Endogenous T-Cell Activation Has Potential Role After CAR T in Myeloma

In an analysis of therapeutic interventions following the failure of chimeric antigen receptor (CAR) T-cell therapy, Rahul ...
ascopubs.org

Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and ...

Randomized controlled trials have generally shown a benefit from accelerated radiotherapy in head and neck squamous cell carcinoma (HNSCC). However, the large randomized United Kingdom trial CHART ...